Edelweiss: Cancer Open Access (ISSN: 2689-6737)

Edelweiss: Cancer Open Access (ISSN: 2689-6737)

Explore journal overview, editorial leadership, indexing, articles in press, latest published work, and highlights from previous issues.

Edelweiss: Cancer Open Access (ISSN: 2689-6737)

Probiotics cancer treatment

Edelweiss: Cancer Open Access journal| Anti-cancer Research articles | Open access cancer therapy Articles

Probiotics are defined as live bacteria and yeasts that exert beneficial effects. The human micro-biome plays many roles in inflammation, drug metabolism even the anti-cancer properties has been identified. By manipulating the micro-biome with interventions such as probiotic administration, we may be able to reduce colorectal cancer risk and improve the safety and effectiveness of cancer therapy. Cell line studies as well as animal models and human studies have shown the therapeutic effects of probiotics in reduction of invasion and metastasis in cancer cells. 

Researchers, authors, reviewers, and readers can use this page to find journal resources connected with Probiotics cancer treatment, including published articles, related academic topics, current issue content, archive material, and manuscript submission information.

Related Articles

Related article links for Probiotics cancer treatment will appear here as matching content is published in Edelweiss: Cancer Open Access (ISSN: 2689-6737). Readers can also browse the journal archive and current issue for connected research.

More Topics in This Journal

Edelweiss: Cancer Open Access (ISSN: 2689-6737)

Subscribe for updates

Subscribe

to get latest updates.


  Life Science

  Health Science

  Chemical Science


Subscribe